Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study.
Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study. Haematologica. 2013 Feb; 98(2):255-63.
-
Adolescent
-
Adult
-
Aged
-
Aged, 80 and over
-
Antibodies, Monoclonal, Murine-Derived
-
Antineoplastic Combined Chemotherapy Protocols
-
Chromosomes, Human, Pair 14
-
Chromosomes, Human, Pair 18
-
Cyclophosphamide
-
Doxorubicin
-
Female
-
Gene Expression Profiling
-
Genes, myc
-
Germinal Center
-
Humans
-
Lymphoma, Large B-Cell, Diffuse
-
Male
-
Middle Aged
-
Prednisone
-
Prognosis
-
Proto-Oncogene Proteins c-bcl-2
-
Rituximab
-
Translocation, Genetic
-
Vincristine
-
Young Adult